Trials / Completed
CompletedNCT04188340
Effect of Su-Man Formula Massage Oil Acupressure on Sleep Quality and Anxiety in Patients With Insomnia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The present study predict that Su-Man formula massage oil acupressure can improved sleep quality.
Detailed description
About 7% person in general population became as insomnia every year, and that has 30% person due to insomnia induces other symptoms such as anxiety. In addition, the incidence of insomnia in the female is 50% more than in the male. Insomnia belong to the scope of bù-mèi in traditional Chinese Medicine (TCM). TCM consider that the cause of insomnia is due to unbalance between yin and yang, and acupressure can treat insomnia. Several studies report that aromatherapy can enhance sleepy. Therefore, the purpose of the present study was to assess the therapeutic effect of Su-Man formula massage oil associates with acupressure on sleepy quality and anxiety lysis. A total 40 patients with insomnia divided into two groups, each group is 20 patients as follows: 1) control group, using bergamot massage oil apply to GV20, GV24 SP6, HT7 and PC6 acupoints, and massage for 10 times before sleep continuously 28 days; 2) test group, using Su-Man formula massage oil ap-ply to GV20, GV24, SP6, HT7 and PC6 acupoints, and massage for 10 times before sleep continuously 28 days. The primary outcome measurement is the Chinese version of Insomnia Severity In-dex(ISI-C), Pittsburgh Sleep Quality Index (CPSQI), and Beck Anxiety Inventory(BAI); The secondary outcome measure is the changes of meridian energy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Su-Man formula massage oil | bergamot massage oil:dilute bergamot essential oil(0.5%) with almond oil Su-Man formula massage oil: mixed 4 different essential oil include bergamot, red mandarin, petit grain bigarade, spikenard and diluted with almond oil 5%. |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2019-04-02
- Completion
- 2019-04-02
- First posted
- 2019-12-05
- Last updated
- 2019-12-05
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04188340. Inclusion in this directory is not an endorsement.